Stocks · Health care · Biological Products, (No Diagnostic Substances)

Denali Therapeutics Inc.

DNLI Clue Score33
United States Fiscal year ends December CIK 0001714899 Results filed 3 Nov 2026

What the insiders did No buying or selling

By person

14 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Baker Bros. Advisors LP entity
Director
—
—
—
3,422,366
$76.28M
+1.0%
Ryan J. Watts
President and CEO
—
—
—
2,417,217
$53.88M
−0.9%
Marc Tessier-Lavigne
Director
—
—
—
1,886,576
$42.05M
+0.3%
Alexander O. Schuth
COFO and Secretary
—
—
—
802,744
$17.89M
+13.9%
Carole Ho
Chief Medical Officer
—
—
—
216,585
$4.83M
+82.3%
Peter Scott Chin
Chief Medical Officer
—
—
—
204,538
$4.56M
−0.8%
Vicki L Sato
Director
—
—
—
107,976
$2.41M
−3.7%
Steve E. Krognes
Director
—
—
—
38,202
$851.52K
−35.4%
Peter S Klein
Director
—
—
—
33,941
$756.54K
+57.9%
Jennifer E. Cook
Director
—
—
—
32,483
$724.05K
+62.1%
Jay T Flatley
Director
—
—
—
22,628
$504.38K
+122.2%
David P Schenkein
Director
—
—
—
21,665
$482.91K
+0.8%
Nancy Thornberry
Director
—
—
—
19,686
$438.80K
+5.4%
Hauwermeiren Timothy Van
Director
—
—
—
17,040
$379.82K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.